France · Delayed Price · Currency is EUR Virbac Earnings Call Transcripts
Fiscal Year 2026
-
H1 2026 saw 7.4% revenue growth and an 18.8% EBIT margin, driven by strong Supercharge platforms and successful integration of acquisitions. Guidance for 2026 targets the upper end of sales growth and a 17% EBIT margin, with continued investment in R&D and capacity.
Fiscal Year 2025
-
2025 saw 7.9% organic growth, strong margin discipline, and record R&D and CapEx investment, with all regions and segments contributing. 2026 guidance targets 5.5%-7.5% revenue growth, 17% EBITDA margin, and continued expansion in pet food and innovation platforms.
-
H1 2025 saw 5.6% organic growth, strong performance in most regions, and robust contributions from new products and acquisitions. EBIT margin declined due to temporary effects, but guidance and long-term targets remain unchanged. CapEx and R&D investments are accelerating.
Fiscal Year 2024
-
Revenue grew 13.6% at constant exchange rates, with strong organic and acquisition-driven gains, and net result rose to EUR 145 million. EBIT adjusted margin hit 16.6%, and 2025 guidance targets 4%-6% revenue growth and stable profitability.
-
Strong organic and acquisition-driven growth led to record profitability, with all major segments and regions contributing. Guidance for 2024 was raised, and major CapEx and R&D investments continue, while leadership transitions are underway.